Biotie Therapies Corp.` s Financial Statement Report for the financial period ended 31 December 2013 and Corporate Governance Statement 2013 have been published. The documents are attached in pdf ...
Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has brought Selincro on the market in Spain. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, ...
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it entered into an agreement to acquire Biotie Therapies Corp. (Nasdaq Helsinki BTH1V; NASDAQ: BITI) for ...
The combined entity includes a promising pipeline of nine clinical-stage drug candidates; a significant international presence with operations in Finland, The United States and Switzerland, and an ...
Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has brought Selincro on the market in Spain. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results